Yüksel Kurban
ORCID: 0000-0002-9409-652X
· 1 paper in corpus
OBJECTIVES: To investigate the efficacy of single daily doses of rofecoxib, a selective inhibitor of cyclooxygenase-2, in dysmenorrhea. METHODS: Fifty-five patients were included in this randomized, placebo-controlled, cross-over study. Pat…